Feb 11, 2021
AstraZeneca says 4th-Q earns triple on cancer drugs sales
AstraZeneca, co-developer of one of the first COVID-19 vaccines to be authorized for widespread use, says fourth-quarter earnings more than tripled amid strong sales of cancer drugs